Contact Us:

Categories News & Media

Nucala Approved for EGPA/CSS Treatment

GlaxoSmithKline (GSK) achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) for adults in the US December 13, 2017:  GSK announced that the US Food and more »


Read More

#GivingTuesday Matching Gift Challenge

#GivingTuesday is a global day of giving fueled by the power of social media and collaboration.  This year your donation can go even further with our generous matching gift challenge! more »


Introducing our 2017-2018 VCRC-VF Fellow

Kaitlin Quinn, MD, is the recipient of the 2017 VCRC-VF Fellowship.  She received her medical degree from New York Medical College in Valhalla, New York.   She completed her Internal Medicine more »


Read More

Brandon’s Book Released – Going the Distance

Brandon Hudgins, professional long-distance runner, GPA/Wegener’s patient and leader of VF Team Brandon, has shared his story in his recently released book, “Going the Distance: The Journey of a Vasculitis more »


Read More

FDA Approves Genentech’s Actemra® for Giant Cell Arteritis

Genentech, a member of the Roche Group, announced today (May 22, 2017) that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) subcutaneous injection for the treatment of more »


Read More